Your browser doesn't support javascript.
loading
Evidence from genome wide association studies implicates reduced control of Epstein-Barr virus infection in multiple sclerosis susceptibility.
Afrasiabi, Ali; Parnell, Grant P; Fewings, Nicole; Schibeci, Stephen D; Basuki, Monica A; Chandramohan, Ramya; Zhou, Yuan; Taylor, Bruce; Brown, David A; Swaminathan, Sanjay; McKay, Fiona C; Stewart, Graeme J; Booth, David R.
Afiliação
  • Afrasiabi A; Centre for Immunology and Allergy Research, Westmead Institute for Medical Research, University of Sydney, Sydney, Australia.
  • Parnell GP; Centre for Immunology and Allergy Research, Westmead Institute for Medical Research, University of Sydney, Sydney, Australia.
  • Fewings N; Centre for Immunology and Allergy Research, Westmead Institute for Medical Research, University of Sydney, Sydney, Australia.
  • Schibeci SD; Centre for Immunology and Allergy Research, Westmead Institute for Medical Research, University of Sydney, Sydney, Australia.
  • Basuki MA; Centre for Immunology and Allergy Research, Westmead Institute for Medical Research, University of Sydney, Sydney, Australia.
  • Chandramohan R; Centre for Immunology and Allergy Research, Westmead Institute for Medical Research, University of Sydney, Sydney, Australia.
  • Zhou Y; Menzies Research Institute Tasmania, University of Tasmania, Hobart, Australia.
  • Taylor B; Menzies Research Institute Tasmania, University of Tasmania, Hobart, Australia.
  • Brown DA; Centre for Immunology and Allergy Research, Westmead Institute for Medical Research, University of Sydney, Sydney, Australia.
  • Swaminathan S; Centre for Immunology and Allergy Research, Westmead Institute for Medical Research, University of Sydney, Sydney, Australia.
  • McKay FC; Centre for Immunology and Allergy Research, Westmead Institute for Medical Research, University of Sydney, Sydney, Australia.
  • Stewart GJ; Centre for Immunology and Allergy Research, Westmead Institute for Medical Research, University of Sydney, Sydney, Australia.
  • Booth DR; Centre for Immunology and Allergy Research, Westmead Institute for Medical Research, University of Sydney, Sydney, Australia. david.booth@sydney.edu.au.
Genome Med ; 11(1): 26, 2019 04 30.
Article em En | MEDLINE | ID: mdl-31039804
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Linfócitos B / Antígenos CD4 / Herpesvirus Humano 4 / Polimorfismo de Nucleotídeo Único / Fator 3 Associado a Receptor de TNF / Esclerose Múltipla Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Genome Med Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Austrália
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Linfócitos B / Antígenos CD4 / Herpesvirus Humano 4 / Polimorfismo de Nucleotídeo Único / Fator 3 Associado a Receptor de TNF / Esclerose Múltipla Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Genome Med Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Austrália